212 related articles for article (PubMed ID: 24072805)
1. Adapting social neuroscience measures for schizophrenia clinical trials, Part 2: trolling the depths of psychometric properties.
Kern RS; Penn DL; Lee J; Horan WP; Reise SP; Ochsner KN; Marder SR; Green MF
Schizophr Bull; 2013 Nov; 39(6):1201-10. PubMed ID: 24072805
[TBL] [Abstract][Full Text] [Related]
2. Adapting social neuroscience measures for schizophrenia clinical trials, part 3: fathoming external validity.
Olbert CM; Penn DL; Kern RS; Lee J; Horan WP; Reise SP; Ochsner KN; Marder SR; Green MF
Schizophr Bull; 2013 Nov; 39(6):1211-8. PubMed ID: 24072806
[TBL] [Abstract][Full Text] [Related]
3. Effort-Based Decision-Making Paradigms for Clinical Trials in Schizophrenia: Part 1—Psychometric Characteristics of 5 Paradigms.
Reddy LF; Horan WP; Barch DM; Buchanan RW; Dunayevich E; Gold JM; Lyons N; Marder SR; Treadway MT; Wynn JK; Young JW; Green MF
Schizophr Bull; 2015 Sep; 41(5):1045-54. PubMed ID: 26142081
[TBL] [Abstract][Full Text] [Related]
4. Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters.
Green MF; Lee J; Ochsner KN
Schizophr Bull; 2013 Nov; 39(6):1192-200. PubMed ID: 24072811
[TBL] [Abstract][Full Text] [Related]
5. Social Cognition Psychometric Evaluation: Results of the Initial Psychometric Study.
Pinkham AE; Penn DL; Green MF; Harvey PD
Schizophr Bull; 2016 Mar; 42(2):494-504. PubMed ID: 25943125
[TBL] [Abstract][Full Text] [Related]
6. Social Cognition Psychometric Evaluation: Results of the Final Validation Study.
Pinkham AE; Harvey PD; Penn DL
Schizophr Bull; 2018 Jun; 44(4):737-748. PubMed ID: 28981848
[TBL] [Abstract][Full Text] [Related]
7. Measurement issues in the use of cognitive neuroscience tasks in drug development for impaired cognition in schizophrenia: a report of the second consensus building conference of the CNTRICS initiative.
Barch DM; Carter CS;
Schizophr Bull; 2008 Jul; 34(4):613-8. PubMed ID: 18499705
[TBL] [Abstract][Full Text] [Related]
8. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.
Green MF; Nuechterlein KH; Kern RS; Baade LE; Fenton WS; Gold JM; Keefe RS; Mesholam-Gately R; Seidman LJ; Stover E; Marder SR
Am J Psychiatry; 2008 Feb; 165(2):221-8. PubMed ID: 18172017
[TBL] [Abstract][Full Text] [Related]
9. The evaluation study for social cognition measures in Japan: Psychometric properties, relationships with social function, and recommendations.
Akiyama H; Okubo R; Toyomaki A; Miyazaki A; Hattori S; Nohara M; Sasaki Y; Kubota R; Okano H; Takahashi K; Hasegawa Y; Wada I; Uchino T; Takeda K; Ikezawa S; Nemoto T; Ito YM; Hashimoto N
Asian J Psychiatr; 2024 May; 95():104003. PubMed ID: 38518537
[TBL] [Abstract][Full Text] [Related]
10. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
Nuechterlein KH; Green MF; Kern RS; Baade LE; Barch DM; Cohen JD; Essock S; Fenton WS; Frese FJ; Gold JM; Goldberg T; Heaton RK; Keefe RS; Kraemer H; Mesholam-Gately R; Seidman LJ; Stover E; Weinberger DR; Young AS; Zalcman S; Marder SR
Am J Psychiatry; 2008 Feb; 165(2):203-13. PubMed ID: 18172019
[TBL] [Abstract][Full Text] [Related]
11. Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.
Ludwig KA; Pinkham AE; Harvey PD; Kelsven S; Penn DL
Schizophr Res; 2017 Dec; 190():136-143. PubMed ID: 28302395
[TBL] [Abstract][Full Text] [Related]
12. Implementation considerations for multisite clinical trials with cognitive neuroscience tasks.
Keefe RS; Harvey PD
Schizophr Bull; 2008 Jul; 34(4):656-63. PubMed ID: 18495645
[TBL] [Abstract][Full Text] [Related]
13. Psychometric properties of performance-based measurements of functional capacity: test-retest reliability, practice effects, and potential sensitivity to change.
Leifker FR; Patterson TL; Bowie CR; Mausbach BT; Harvey PD
Schizophr Res; 2010 Jun; 119(1-3):246-52. PubMed ID: 20399613
[TBL] [Abstract][Full Text] [Related]
14. Going from social neuroscience to schizophrenia clinical trials.
Green MF; Penn DL
Schizophr Bull; 2013 Nov; 39(6):1189-91. PubMed ID: 24072810
[TBL] [Abstract][Full Text] [Related]
15. Social and nonsocial cognition in bipolar disorder and schizophrenia: relative levels of impairment.
Lee J; Altshuler L; Glahn DC; Miklowitz DJ; Ochsner K; Green MF
Am J Psychiatry; 2013 Mar; 170(3):334-41. PubMed ID: 23450289
[TBL] [Abstract][Full Text] [Related]
16. Psychometrics of social cognitive measures for psychosis treatment research.
Davidson CA; Lesser R; Parente LT; Fiszdon JM
Schizophr Res; 2018 Mar; 193():51-57. PubMed ID: 28648914
[TBL] [Abstract][Full Text] [Related]
17. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A
Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396
[TBL] [Abstract][Full Text] [Related]
18. Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients.
Georgiades A; Davis VG; Atkins AS; Khan A; Walker TW; Loebel A; Haig G; Hilt DC; Dunayevich E; Umbricht D; Sand M; Keefe RSE
Schizophr Res; 2017 Dec; 190():172-179. PubMed ID: 28433500
[TBL] [Abstract][Full Text] [Related]
19. Self and other in schizophrenia: a cognitive neuroscience perspective.
Fisher M; McCoy K; Poole JH; Vinogradov S
Am J Psychiatry; 2008 Nov; 165(11):1465-72. PubMed ID: 18708487
[TBL] [Abstract][Full Text] [Related]
20. Temporal stability and moderating effects of age and sex on CNTRaCS task performance.
Strauss ME; McLouth CJ; Barch DM; Carter CS; Gold JM; Luck SJ; MacDonald AW; Ragland JD; Ranganath C; Keane BP; Silverstein SM
Schizophr Bull; 2014 Jul; 40(4):835-44. PubMed ID: 23817024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
